Eisenberger MA - Search Results

1

A prospective study of suramin-induced peripheral neuropathy.

Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. Chaudhry V, et al. Among authors: eisenberger ma. Brain. 1996 Dec;119 ( Pt 6):2039-52. doi: 10.1093/brain/119.6.2039. Brain. 1996. PMID: 9010008 Clinical Trial.

2

Cutaneous eruptions from suramin. A clinical and histopathologic study of 60 patients.

Lowitt MH, Eisenberger M, Sina B, Kao GF. Lowitt MH, et al. Arch Dermatol. 1995 Oct;131(10):1147-53. doi: 10.1001/archderm.131.10.1147. Arch Dermatol. 1995. PMID: 7574831 Review.

3

Suramin.

Eisenberger MA, Sinibaldi V, Reyno L. Eisenberger MA, et al. Cancer Pract. 1995 May-Jun;3(3):187-9. Cancer Pract. 1995. PMID: 7599677 Review. No abstract available.

4

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.

Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, Tkaczuk KH, Lowitt MH, Hemady RK, Jacobs SC, et al. Eisenberger MA, et al. J Clin Oncol. 1995 Sep;13(9):2174-86. doi: 10.1200/JCO.1995.13.9.2174. J Clin Oncol. 1995. PMID: 7666076 Clinical Trial.

5

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin.

Reyno LM, Egorin MJ, Eisenberger MA, Sinibaldi VJ, Zuhowski EG, Sridhara R. Reyno LM, et al. Among authors: eisenberger ma. J Clin Oncol. 1995 Sep;13(9):2187-95. doi: 10.1200/JCO.1995.13.9.2187. J Clin Oncol. 1995. PMID: 7666077 Clinical Trial.

6

Suramin.

Eisenberger MA, Reyno LM. Eisenberger MA, et al. Cancer Treat Rev. 1994 Jul;20(3):259-73. doi: 10.1016/0305-7372(94)90003-5. Cancer Treat Rev. 1994. PMID: 8020006 Review. No abstract available.

7

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.

Jodrell DI, Reyno LM, Sridhara R, Eisenberger MA, Tkaczuk KH, Zuhowski EG, Sinibaldi VJ, Novak MJ, Egorin MJ. Jodrell DI, et al. Among authors: eisenberger ma. J Clin Oncol. 1994 Jan;12(1):166-75. doi: 10.1200/JCO.1994.12.1.166. J Clin Oncol. 1994. PMID: 8270974 Clinical Trial.

8

Suramin, an active drug for prostate cancer: interim observations in a phase I trial.

Eisenberger MA, Reyno LM, Jodrell DI, Sinibaldi VJ, Tkaczuk KH, Sridhara R, Zuhowski EG, Lowitt MH, Jacobs SC, Egorin MJ. Eisenberger MA, et al. J Natl Cancer Inst. 1993 Apr 21;85(8):611-21. doi: 10.1093/jnci/85.8.611. J Natl Cancer Inst. 1993. PMID: 8468719 Clinical Trial.

9

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

Sridhara R, Eisenberger MA, Sinibaldi VJ, Reyno LM, Egorin MJ. Sridhara R, et al. Among authors: eisenberger ma. J Clin Oncol. 1995 Dec;13(12):2944-53. doi: 10.1200/JCO.1995.13.12.2944. J Clin Oncol. 1995. PMID: 8523059

10

Ocular symptoms and signs associated with suramin sodium treatment for metastatic cancer of the prostate.

Hemady RK, Sinibaldi VJ, Eisenberger MA. Hemady RK, et al. Among authors: eisenberger ma. Am J Ophthalmol. 1996 Mar;121(3):291-6. doi: 10.1016/s0002-9394(14)70277-6. Am J Ophthalmol. 1996. PMID: 8597272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page